654 3323 No. PACE IR2018/007 Date: 9 February 2018 Subject: Explanation of the Operating Results for the Third Quarter of the Year 2017 (Q3 2017) Changing over 20% To: The President The Stock Exchange
AIT (SVP-SEC) 015E/2016 May 9, 2017 Subject: Management's Discussion and Analysis of Operating Results for Q-2016 To: The President of The Stock Exchange of Thailand Summary of Operations Q1- 2016
-1- AIT (AVP-SEC) 023E/2017 10 August, 2017 Subject: Management's Discussion and Analysis of Operating Results for Q2-2017 To: The President of The Stock Exchange of Thailand Summary of Operations Q2
percent To The President of the Stock Exchange of Thailand Management’s Discussion and Analysis Consolidated Financial Results for the three-month and the six-month : Q2/2017 For the three-month ended 30
Microsoft Word - 2019-Q3_MDA_Eng_R1.docx No. CAZ 019-2019 12 November 2019 Subject: Management Discussion and Analysis 3rd Quarter ended 30 September 2019 Attention: The President The Stock
: President The Stock Exchange of Thailand Since the Board of Directors of Filter Vision Public Company Limited (“the Company” or “FVC”) dated December 14, 2017 resolved to approve the signing of Hi Healthcare
Ref. No. 1902-009EN February 21, 2019 Subject: Operating Result Clarification for the year 2018 (Ending December 31, 2018) To: Director and Manager of the Stock Exchange of Thailand Ubis (Asia
Page 1 of 2 Ref. PDI/BK-BS-43/2017 08 th August 2017 To: President The Stock Exchange of Thailand Re: Clarification on Company’s performance of the 2 nd Quarter and 1 st Half 2017 For the second
Page 1 of 2 Ref. PDI/BK-BS-063/2017 7 th November 2017 To: President The Stock Exchange of Thailand Re: Clarification on Company’s performance of the 3 rd Quarter and 9- month Year to date 2017 For
31, 2019) To Director and Manager of the Stock Exchange of Thailand Ubis (Asia) Public Company Limited (“the Company”) would like to clarify on the performance and the financial status had varied over